Probiotics and Antimicrobial Proteins Микробиология
The Application of Engineered Probiotics in the Prophylaxis and Control of Salmonella Infections
Аннотация
Salmonella is a major zoonotic pathogen responsible for human and animal infections, posing significant challenges to public health and disease control. Its pathogenicity relies on a suite of molecular mechanisms mediating bacterial adhesion, invasion, intracellular persistence, immune evasion, and host–microbe crosstalk. Conventional probiotics mitigate Salmonella infection through competitive exclusion, secretion of antimicrobial metabolites, intestinal barrier reinforcement, microbiota remodelling and host immunomodulation. However, their efficacy varies depending on strain, host, dose, formulation, delivery route, infection model, and intervention timing. Genetically engineered probiotics and complementary non-genetic functional enhancement strategies offer opportunities to introduce or tailor defined antimicrobial, biosensing, colonisation or ecological functions. This narrative review summarizes recent progress in genetically engineered probiotics, non-genetic functional enhancement of probiotics, and attenuated pathogen strains for Salmonella control. Genetically engineered probiotics are equipped with programmable regulatory and antibacterial modules, while non-genetic probiotic approaches include probiotic–nanomaterial biohybrids, metabolically adapted strains and microbiome-directed substrate interventions. Preclinical studies show these microbial systems can provide programmable, targeted, context-dependent functions to reduce Salmonella colonisation, though their performance is also highly context-dependent. Future studies should focus on improving functional stability, standardizing efficacy and biosafety evaluation, clarifying ecological and environmental risks, and addressing manufacturing, formulation, quality-control, and regulatory requirements for translational development.